Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies.
Mitchell P, McAllister I, Larsen M, Staurenghi G, Korobelnik JF, Boyer DS, Do DV, Brown DM, Katz TA, Berliner A, Vitti R, Zeitz O, Metzig C, Lu C, Holz FG.
Mitchell P, et al. Among authors: metzig c.
Ophthalmol Retina. 2018 Oct;2(10):988-996. doi: 10.1016/j.oret.2018.02.011. Epub 2018 Mar 31.
Ophthalmol Retina. 2018.
PMID: 31047501
Free article.